Gargis Amy S, Kalman Lisa, Lubin Ira M
Division of Preparedness and Emerging Infections, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Division of Laboratory Systems, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Clin Microbiol. 2016 Dec;54(12):2857-2865. doi: 10.1128/JCM.00949-16. Epub 2016 Aug 10.
Clinical microbiology and public health laboratories are beginning to utilize next-generation sequencing (NGS) for a range of applications. This technology has the potential to transform the field by providing approaches that will complement, or even replace, many conventional laboratory tests. While the benefits of NGS are significant, the complexities of these assays require an evolving set of standards to ensure testing quality. Regulatory and accreditation requirements, professional guidelines, and best practices that help ensure the quality of NGS-based tests are emerging. This review highlights currently available standards and guidelines for the implementation of NGS in the clinical and public health laboratory setting, and it includes considerations for NGS test validation, quality control procedures, proficiency testing, and reference materials.
临床微生物学和公共卫生实验室正开始将下一代测序(NGS)用于一系列应用。这项技术有潜力通过提供能够补充甚至取代许多传统实验室检测的方法来变革该领域。虽然NGS的益处显著,但这些检测的复杂性需要一套不断发展的标准来确保检测质量。有助于确保基于NGS的检测质量的监管和认证要求、专业指南及最佳实践正在不断涌现。本综述重点介绍了目前在临床和公共卫生实验室环境中实施NGS的可用标准和指南,其中包括对NGS检测验证、质量控制程序、能力验证和参考材料的考量。